BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29528966)

  • 21. Immunosuppression in the era of biological agents.
    Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
    Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal Transplantation: International Outcomes.
    Ganoza AJ; Farmer DG; Marquez MA; Mazariegos GV
    Clin Transpl; 2014; ():49-54. PubMed ID: 26281126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell costimulation blockade and organ transplantation: a change of philosophy for transplant immunologists?
    Goldstein DR
    J Immunol; 2011 Mar; 186(5):2691-2. PubMed ID: 21325217
    [No Abstract]   [Full Text] [Related]  

  • 24. Future trends in organ transplant recipients--important issues for dermatologists.
    Zecher D; Steiger J
    Curr Probl Dermatol; 2012; 43():71-80. PubMed ID: 22377921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplant tolerance: new insights and strategies for long-term allograft acceptance.
    Ruiz P; Maldonado P; Hidalgo Y; Gleisner A; Sauma D; Silva C; Saez JJ; Nuñez S; Rosemblatt M; Bono MR
    Clin Dev Immunol; 2013; 2013():210506. PubMed ID: 23762087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Targets for the Prevention of Chronic Rejection after Thoracic Organ Transplantation.
    Heim C; Gocht A; Weyand M; Ensminger S
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):20-30. PubMed ID: 29258125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting T-cell memory: where do we stand?
    Valujskikh A
    Curr Opin Organ Transplant; 2008 Aug; 13(4):344-9. PubMed ID: 18685328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes and quality of life after intestine transplantation.
    Sudan D
    Curr Opin Organ Transplant; 2010 Jun; 15(3):357-60. PubMed ID: 20445450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of new non-nephrotoxic immunosuppressive drugs in kidney transplantation, especially after ischemia-reperfusion injury].
    Charpentier B; Beaudreuil S; Francois H; Jacquet A; Durrbach A
    Bull Acad Natl Med; 2011; 195(4-5):899-912; discussion 912. PubMed ID: 22375359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY; Kaneku H; Farmer DG
    Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant immunology for non-immunologist.
    Heeger PS; Dinavahi R
    Mt Sinai J Med; 2012; 79(3):376-87. PubMed ID: 22678861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging role of carbon monoxide in intestinal transplantation.
    Dugbartey GJ
    Biomed Pharmacother; 2021 Nov; 143():112237. PubMed ID: 34649361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assurance of intestinal transplant quality].
    Saliutin RV; Palianytsia SS; Davydova TI; Panchenko LA; Mel'nychuk IM; Buslovych OV; Sokolov MF
    Klin Khir; 2014 Jun; (6):17-8. PubMed ID: 25252545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What Is the Future of Generics in Transplantation?
    van Gelder T
    Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ transplantation in the twenty-first century.
    Weber M; Deng S; Olthoff K; Naji A; Barker CF; Shaked A; Brayman KL
    Urol Clin North Am; 1998 Feb; 25(1):51-61. PubMed ID: 9529536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conclusions from the symposium.
    Campistol JM
    Transplant Proc; 2010 Nov; 42(9 Suppl):S47-8. PubMed ID: 21095453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refining the definition and management of high-risk organ transplant recipients.
    Hricik DE
    Curr Opin Organ Transplant; 2009 Dec; 14(6):634-5. PubMed ID: 19920762
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction therapy: why, when, and which agent?
    Krischock L; Marks SD
    Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.